Two Sigma Advisers’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-8,470
| Closed | -$134K | – | 2595 |
|
|
2023
Q3 | $134K | Sell |
8,470
-755
| -8% | -$11.9K | ﹤0.01% | 2168 |
|
|
2023
Q2 | $153K | Sell |
9,225
-2,485
| -21% | -$41.3K | ﹤0.01% | 2140 |
|
|
2023
Q1 | $164K | Sell |
11,710
-805
| -6% | -$11.3K | ﹤0.01% | 2308 |
|
|
2022
Q4 | $127K | Sell |
12,515
-7,185
| -36% | -$73.1K | ﹤0.01% | 2265 |
|
|
2022
Q3 | $252K | Buy |
19,700
+320
| +2% | +$4.09K | ﹤0.01% | 2126 |
|
|
2022
Q2 | $399K | Buy |
19,380
+4,930
| +34% | +$102K | ﹤0.01% | 2023 |
|
|
2022
Q1 | $543K | Buy |
14,450
+2,715
| +23% | +$102K | ﹤0.01% | 1948 |
|
|
2021
Q4 | $1.13M | Buy |
11,735
+3,005
| +34% | +$290K | ﹤0.01% | 1504 |
|
|
2021
Q3 | $1.26M | Buy |
8,730
+5,745
| +192% | +$830K | ﹤0.01% | 1505 |
|
|
2021
Q2 | $551K | Sell |
2,985
-1,030
| -26% | -$190K | ﹤0.01% | 1909 |
|
|
2021
Q1 | $988K | Sell |
4,015
-2,640
| -40% | -$650K | ﹤0.01% | 1659 |
|
|
2020
Q4 | $1.88M | Buy |
6,655
+2,670
| +67% | +$753K | 0.01% | 1299 |
|
|
2020
Q3 | $956K | Buy |
3,985
+2,050
| +106% | +$492K | ﹤0.01% | 1519 |
|
|
2020
Q2 | $642K | Buy |
1,935
+940
| +94% | +$312K | ﹤0.01% | 1779 |
|
|
2020
Q1 | $226K | Sell |
995
-345
| -26% | -$78.4K | ﹤0.01% | 2125 |
|
|
2019
Q4 | $330K | Sell |
1,340
-580
| -30% | -$143K | ﹤0.01% | 2036 |
|
|
2019
Q3 | $109K | Sell |
1,920
-10
| -0.5% | -$568 | ﹤0.01% | 2107 |
|
|
2019
Q2 | $91K | Hold |
1,930
| – | – | ﹤0.01% | 2220 |
|
|
2019
Q1 | $104K | Buy |
1,930
+215
| +13% | +$11.6K | ﹤0.01% | 2187 |
|
|
2018
Q4 | $74K | Buy |
1,715
+1,040
| +154% | +$44.9K | ﹤0.01% | 2246 |
|
|
2018
Q3 | $40K | Buy |
+675
| New | +$40K | ﹤0.01% | 2186 |
|